Clinical Trials
33 trialsNCT07205315 2026-05-27
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
Grit Biotechnology
Phase EARLY_PHASE1 Recruiting
NCT06937567 2026-05-26
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
Zhejiang University
Phase EARLY_PHASE1 Recruiting
NCT05498792 2026-05-22
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
Fox Chase Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT03594630 2026-05-20
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT06097962 2026-05-20
Safety and Efficacy of NK510 to Treat NSCLC
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1 Recruiting
NCT07595237 2026-05-19
A IIT Study of 177Lu-DOTA-SNA040
SmartNuclide Biopharma
Phase EARLY_PHASE1 Recruiting
NCT07597772 2026-05-19
Preliminary Trial of SNA014 for Pancreatic Cancer
SmartNuclide Biopharma
Phase EARLY_PHASE1 Recruiting
NCT04187703 2026-05-18
5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT06400485 2026-05-18
AMT-676 in Patients With Advanced Solid Tumors
Multitude Therapeutics Inc.
Phase EARLY_PHASE1 Recruiting
NCT06736275 2026-05-15
A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors
Jiangsu Nutai Biologics Co., Ltd
Phase EARLY_PHASE1 Recruiting
NCT07590310 2026-05-15
Clinical Application of CAIX-Targeted PET Imaging in Tumors
Peking University Cancer Hospital & Institute
Phase EARLY_PHASE1 Recruiting
NCT06637306 2026-05-14
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
Icahn School of Medicine at Mount Sinai
Phase EARLY_PHASE1 Recruiting
NCT07485049 2026-05-14
BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors
St. Joseph's Hospital and Medical Center, Phoenix
Phase EARLY_PHASE1 Recruiting
NCT07586904 2026-05-14
Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.
Xijing Hospital
Phase EARLY_PHASE1 Recruiting
NCT02172651 2026-05-13
Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
Dana-Farber Cancer Institute
Phase EARLY_PHASE1 Recruiting
NCT07128355 2026-05-13
Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
Massachusetts General Hospital
Phase EARLY_PHASE1 Recruiting
NCT07395479 2026-05-13
A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Recruiting
NCT07337785 2026-05-12
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
Tongji Hospital
Phase EARLY_PHASE1 Recruiting
NCT07210632 2026-05-11
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT07577206 2026-05-11
Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.
National Cancer Institute, Naples
Phase EARLY_PHASE1 Recruiting
NCT05086250 2026-05-08
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Recruiting
NCT06819228 2026-05-08
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT06828588 2026-05-08
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT07220447 2026-05-08
L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
City of Hope Medical Center
Phase EARLY_PHASE1 Recruiting
NCT07284069 2026-05-07
SENIPERA
University of Aarhus
Phase EARLY_PHASE1 Recruiting
NCT06636162 2026-05-06
Window of Opportunity Study of DSP-0390 in Gliomas
Washington University School of Medicine
Phase EARLY_PHASE1 Recruiting
NCT07319195 2026-05-06
WINIT-BC
University of Pennsylvania
Phase EARLY_PHASE1 Recruiting
NCT04744116 2026-05-05
Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT05245058 2026-05-05
SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors
Shanghai Pharmaceuticals Holding Co., Ltd
Phase EARLY_PHASE1 Recruiting
NCT06123286 2026-05-05
Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Recruiting
NCT07261657 2026-05-05
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
Northwestern University
Phase EARLY_PHASE1 Recruiting
NCT05645523 2026-05-04
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
St. Jude Children's Research Hospital
Phase EARLY_PHASE1 Recruiting
NCT06810336 2026-05-04
Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery
University of Virginia
Phase EARLY_PHASE1 Recruiting